Hannah Kaiser
Impact in
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Immunotherapy and Immune Responses 2
- Immunodeficiency and Autoimmune Disorders 1
- Toxin Mechanisms and Immunotoxins 1
- Oncology 4
- Peptidase Inhibition and Analysis 1
- Cancer Treatment and Pharmacology 1
- Co-authors
- B Bödey (5 shared papers)Sandra Siegel (1 shared paper)F.-W. Rath (1 shared paper)Thomas Neumann (1 shared paper)Gregory P. Sutton (1 shared paper)Hal E. Broxmeyer (2 shared papers)Ned B. Hornback (1 shared paper)Homayoon Shidnia (1 shared paper)
- Journals
- Journal of Hepatology (1 paper)JHEP Reports (1 paper)PubMed (12 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Hannah Kaiser
14 papers receiving 210 citations
Peers
Comparison fields: 5 of 56
- Immunology 123
- Oncology 68
- Biotechnology 15
- Radiology, Nuclear Medicine and Imaging 34
- Molecular Biology 73
Countries citing papers authored by Hannah Kaiser
This map shows the geographic impact of Hannah Kaiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah Kaiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah Kaiser more than expected).
Fields of papers citing papers by Hannah Kaiser
This network shows the impact of papers produced by Hannah Kaiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah Kaiser. The network helps show where Hannah Kaiser may publish in the future.
Co-authors
The 25 scholars most cited alongside Hannah Kaiser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Failure of cancer vaccines: the significant limitations of this approach to immunotherapy. | 2000 | 121 |
| 2 | Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies. | 1996 | 26 |
| 3 | Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions. | 1998 | 18 |
| 4 | A permanent cell line of the crayfish Orconectes limosus as a potential model in comparative oncology. | 2001 | 11 |
| 5 | Intrathymic non-lymphatic hematopoiesis during mammalian ontogenesis. | 1999 | 11 |
| 6 | Synergistic cytotoxic and antitumor effects of irradiation and taxol on human HeLa cervix carcinoma and mouse B16 melanoma cells. | 1995 | 10 |
| 7 | Recombinant human interleukin-1 alpha: a potent bio-immunomodifier in vivo in immunosuppressed mice induced by cyclophosphamide, retroviral infection and surgical stress. | 1994 | 7 |
| 8 | Cell culture observations of human postnatal thymic epithelium: an in vitro model for growth and humoral influence on intrathymic T lymphocyte maturation. | 1997 | 4 |
| 9 | Role of PCNA in differentiating between malignant mesothelioma and mesothelial hyperplasia: prognostic considerations. | 1997 | 4 |
| 10 | Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms. | 2007 | 2 |
| 11 | 2020 | 2 | |
| 12 | 2025 | 2 | |
| 13 | Pleomorphic T-cell lymphoma with chondropathia tuberosa; a case report and review. | 1999 | 1 |
| 14 | Bio-immunotherapy for cancer in experimental studies and clinical application: current status and future challenges. | 1995 | 1 |
About Hannah Kaiser
Hannah Kaiser is a scholar working on Immunology, Oncology, Biotechnology, Ecology and Epidemiology, having authored 14 papers that have together received 220 indexed citations. Recurring topics across this work include Cancer Research and Treatments (3 papers), Immunotherapy and Immune Responses (2 papers), Hepatitis B Virus Studies (2 papers), Lymphoma Diagnosis and Treatment (1 paper), Immunodeficiency and Autoimmune Disorders (1 paper), Peptidase Inhibition and Analysis (1 paper), Cancer Treatment and Pharmacology (1 paper) and Toxin Mechanisms and Immunotoxins (1 paper). The work is most often cited by research in Immunology (123 citations), Oncology (68 citations), Biotechnology (15 citations), Radiology, Nuclear Medicine and Imaging (34 citations) and Molecular Biology (73 citations). Hannah Kaiser has collaborated with scholars based in United States, Germany and France. Frequent co-authors include B Bödey, Sandra Siegel, F.-W. Rath, Thomas Neumann, Gregory P. Sutton, Hal E. Broxmeyer, Ned B. Hornback, Homayoon Shidnia, Wu B and Lu Li. Their work appears in journals such as Journal of Hepatology, JHEP Reports and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.